CHD: “Merck Knew Its Popular Asthma Drug Could Lead Kids to Commit Suicide, Lawsuits Allege”

CHD: “Merck Knew Its Popular Asthma Drug Could Lead Kids to Commit Suicide, Lawsuits Allege”

Posted By: hobie [Send E-Mail]
Date: Wednesday, 28-Jun-2023 05:49:13
http://www.rumormill.news/225079

=====Merck Knew Its Popular Asthma Drug Could Lead Kids to Commit Suicide, Lawsuits AllegeAccording to a Reuters investigation, parents trying to sue Merck were “stymied by one of Corporate America’s most effective liability shields: the doctrine of federal preemption” which says federal law and federal regulations supersede state laws, but some are now moving forward.by Michael Nevradakis, Ph.D.Dozens of patients, including many children, died by suicide or suffered from neuropsychiatric problems after taking Singulair, Merck’s allergy and asthma medication, according to lawsuits that are finally proceeding, after decades of delays and legal challenges, Reuters reported.Merck is accused of downplaying early evidence of Singulair’s impact on the brain. These claims “later faced intense scrutiny,” leading to “a raft of lawsuits alleging [Merck] knew … that the drug could impact the brain and that it minimized the potential for psychiatric problems in statements to regulators.”Singulair, also known as montelukast, is available to adults and children as a medication for severe allergies and asthma. The drug “blocks chemicals, called leukotrienes, in the body,” according to Dr. Michelle Perro, a pediatrician. Leukotrienes “can be involved in the precipitation of asthma and can cause respiratory symptoms, as well as inflammation of the airways,” Perro told The Defender.Numerous public comments about Singulair’s side effects were submitted in 2019, …”Full article:https://childrenshealthdefense.org/defender/singulair-merck-asthma-kids-suicide/*************************************************************

https://www.rumormillnews.com/cgi-bin/forum.cgi?read=225079

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a comment